Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| vTv Therapeutics Inc.VTVT · Entity 6614 | Director | June 19, 2023 | June 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
vTv Therapeutics Inc.
Report date June 19, 2023 · Filed June 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2033-06-19 | Direct | 75,000 |
Reported balance
After 2023-06-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-19 · Grant · Acquired 75,000 · Balance 75,000 F1: This option vests in full on the one-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests in full on the one-year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2023 Filed Jun 21, 2023 16:16 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | GrantDirector stock option (right to buy) · Derivative | 75,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001641489-23-000030 · wk-form4_1687378603.xml · derivative · entry 1 Weiner Howard L. · CIK 0001710056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Class A Common Stock · 75,000 shares Expires 2033-06-19 F1 · derivative.exercise_date: This option vests in full on the one-year anniversary of the date of grant. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 16:14 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | GrantDirector stock option (right to buy) · Derivative | 105,128 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0000950142-22-002108 · es220267482_4-weiner.xml · derivative · entry 1 Weiner Howard L. · CIK 0001710056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,128 Underlying: Class A Common Stock · 105,128 shares Expires 2032-07-01 F1 · derivative.exercise_date: An option to purchase 80,128 shares vested immediately on July 1, 2022. The remaining option to purchase 25,000 shares vests on June 1, 2023. Read SEC document |
| May 03, 2021 Filed May 5, 2021 16:42 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | GrantDirector stock option (right to buy) · Derivative | 15,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001562180-21-003229 · primarydocument.xml · derivative · entry 1 Weiner Howard L. · CIK 0001710056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,250 Underlying: Class A Common Stock · 15,000 shares Expires 2031-05-03 F1 · derivative.exercise_date: The option vests in monthly installments over the three year period beginning May 3, 2021. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 16:26 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | GrantDirector stock option (right to buy) · Derivative | 15,000 | $2.65 Strike: $2.65 | $39,750.00 |
DisclosureSEC source: 0001562180-20-004483 · primarydocument.xml · derivative · entry 1 Weiner Howard L. · CIK 0001710056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,250 Underlying: Class A common stock · 15,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The option vests in monthly installments over the three year period beginning June 11, 2020. Read SEC document |
| April 29, 2019 Filed May 1, 2019 16:41 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | GrantDirector stock option (right to buy) · Derivative | 15,000 | $1.45 Strike: $1.45 | $21,750.00 |
DisclosureSEC source: 0001562180-19-002471 · primarydocument.xml · derivative · entry 1 Weiner Howard L. · CIK 0001710056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,250 Underlying: Class A common stock · 15,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: The option vests in monthly equal installments over the three year period beginning on April 29, 2019. Read SEC document |
| April 30, 2018 Filed May 2, 2018 16:27 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | GrantDirector stock option (right to buy) · Derivative | 26,250 | $1.79 Strike: $1.79 | $46,987.50 |
DisclosureSEC source: 0001562180-18-002114 · primarydocument.xml · derivative · entry 1 Weiner Howard L. · CIK 0001710056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Class A common stock · 26,250 shares Expires 2028-04-30 F1 · derivative.exercise_date: An option to acquire 2,813 shares is immediately vested on April 30, 2018. The remaining portion of the option grant (an option to acquire 23,437 shares) vests in monthly equal installments over the three year period beginning on April 30, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.